Comparative surface antimicrobial properties of synthetic biocides and novel human apolipoprotein E derived antimicrobial peptides

Biomaterials

Volumn 34, Issue 22, 2013, Pages 5453-5464

  Forbes, Sarah ^a   McBain, Andrew J ^a   Felton Smith, Susan ^b   Jowitt, Thomas A ^a   Birchenough, Holly L ^a   Dobson, Curtis B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Ai2 Ltd   (United Kingdom)

Author keywords

Antimicrobial; Biocompatibility; Biofilm; Peptide

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTI-MICROBIAL ACTIVITY; ANTI-MICROBIAL PROPERTIES; ANTIMICROBIAL; ANTIMICROBIAL FUNCTIONS; ANTIMICROBIAL PEPTIDE; MEMBRANE INTERACTIONS; STAPHYLOCOCCUS AUREUS;

ASSOCIATION REACTIONS; BACTERIA; BIOCIDES; BIOCOMPATIBILITY; BIOFILMS; BIOMEDICAL EQUIPMENT; CELL MEMBRANES; COATINGS; CYTOTOXICITY; ENZYME INHIBITION; LIPID BILAYERS; LIPOPROTEINS; PEPTIDES; PHOSPHOLIPIDS; POLYETHYLENES; POROUS MATERIALS;

TUNGSTEN COMPOUNDS;

APOLIPOPROTEIN E; BIOCIDE; POLYPEPTIDE ANTIBIOTIC AGENT;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BIOFILM; COMPARATIVE STUDY; CONTROLLED STUDY; HYDROGEL; NONHUMAN; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTY;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; APOLIPOPROTEINS E; BACTERIA; BIOCOMPATIBLE MATERIALS; BIREFRINGENCE; CELL DEATH; DISINFECTANTS; FIBROBLASTS; FLUORESCEIN; HUMANS; MEMBRANES, ARTIFICIAL; MICE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; POLYMERS; QUARTZ CRYSTAL MICROBALANCE TECHNIQUES;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 84877604023     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.087     Document Type: Article

References (62)

1. Campanac C., Pineau L., Payard A., Baziard-Mouysset G., Roques C. Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother 2002, 46:1469-1474.
2. Bjarnsholt T., Kirketerp-MØller K., Kristiansen S., Phipps R., Nielsen A.K., Jensen P.Ø., et al. Silver against Pseudomonas aeruginosa biofilms. APMIS 2007, 115:921-928.
3. Leid J.G., Willson C.J., Shirtliff M.E., Hassett D.J., Parsek M.R., Jeffers A.K. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-γ-mediated macrophage killing. JImmunol 2005, 175:7512.
4. Darouiche R.O. Treatment of infections associated with surgical implants. NEngl J Med 2004, 350:1422.
5. Gaonkar T.A.P., Sampath L.A.B.A., Modak S.M.P. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an invitro urinary tract model. Infect Control Hosp Epidemiol 2003, 24:506-513.
6. Monteiro D.R., Gorup L.F., Takamiya A.S., Ruvollo-Filho A.C., Camargo ERd, Barbosa D.B. The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver. Int J Antimicrob Agents 2009, 34:103-110.
7. Maki D.G., Stolz S.M., Wheeler S., Mermel L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 1997, 127:257-266.
8. Harris L.G., Tosatti S., Wieland M., Textor M., Richards R.G. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide-functionalized poly(l-lysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004, 25:4135-4148.
9. Madhavan R.V., Rosemary M.J., Mathirappillil R.J., Nandkumar M.A., Krishnan K.V., Krishnan L.K. The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomaterials 2012, 33:3083.
10. Hume E.B.H., Baveja J., Muir B., Schubert T.L., Kumar N., Kjelleberg S., et al. The control of Staphylococcus epidermidis biofilm formation and invivo infection rates by covalently bound furanones. Biomaterials 2004, 25:5023-5030.
11. Gottenbos B., van der Mei H.C., Klatter F., Nieuwenhuis P., Busscher H.J. Invitro and invivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials 2002, 23:1417-1423.
12. Gao G., Lange D., Hilpert K., Kindrachuk J., Zou Y., Cheng J.T.J., et al. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 2011, 32:3899.
13. Ivanov I.E., Morrison A.E., Cobb J.E., Fahey C.A., Camesano T.A. Creating antibacterial surfaces with the peptide chrysophsin-1. ACS Appl Mater Interfaces 2012, 4:5891.
14. Zhang X., Wyss U.P., Pichora D., Goosen M.F.A. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. JPharm Pharmacol 1994, 46:718-724.
15. Veiga A.S., Sinthuvanich C., Gaspar D., Franquelim H.G., Castanho M.A.R.B., Schneider J.P. Arginine-rich self-assembling peptides as potent antibacterial gels. Biomaterials 2012, 33:8907.
16. Fong N., Poole-Warren L.A., Simmons A. Development of sustained-release antibacterial urinary biomaterials through using an antimicrobial as an organic modifier in polyurethane nanocomposites. JBiomed Mater Res Part B 2013, 101B:310.
17. Murata H., Koepsel R.R., Matyjaszewski K., Russell A.J. Permanent, non-leaching antibacterial surfaces: how high density cationic surfaces kill bacterial cells. Biomaterials 2007, 28:4870-4879.
18. Majumdar P., Crowley E., Htet M., Stafslien S.J., Daniels J., VanderWal L., et al. Combinatorial materials research applied to the development of new surface coatings XV: an investigation of polysiloxane anti-fouling/fouling-release coatings containing tethered quaternary ammonium salt groups. ACS Comb Sci 2011, 13:298.
19. Zhang W., Chu P.K., Ji J., Zhang Y., Fu R.K.Y., Yan Q. Antibacterial properties of plasma-modified and triclosan or bronopol coated polyethylene. Polymer 2006, 47:931-936.
20. Knetsch M.L.W., Koole L.H. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymer 2011, 3:340.
21. McBain A.J., Ledder R.G., Sreenivasan P., Gilbert P. Selection for high-level resistance by chronic triclosan exposure is not universal. JAntimicrob Chemother 2004, 53:772.
22. Braoudaki M., Hilton A.C. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. JClin Microbiol 2004, 42:73-78.
23. Braoudaki M., Hilton A.C. Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E.coli O55 compared to E.coli O157. FEMS Microbiol Lett 2004, 235:305-309.
24. Chuanchuen R., Beinlich K., Hoang T.T., Becher A., Karkhoff-Schweizer R.R., Schweizer H.P. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 2001, 45:428-432.
25. Kelly B.A., Neil S., McKnight A., Santos J.M., Sinnis P., Jack E.R., et al. Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity. FEBS J 2007, 274:4511.
26. Statz A.R., Park J.P., Chongsiriwatana N.P., Barron A.E., Messersmith P.B. Surface-immobilised antimicrobial peptoids. Biofouling 2008, 24:439-448.
27. Kazemzadeh-Narbat M., Kindrachuk J., Duan K., Jenssen H.V., Hancock R.E.W., Wang R. Antimicrobial peptides on calcium phosphate-coated titanium forthe prevention of implant-associated infections. Biomaterials 2010, 31:9519-9526.
28. Willcox M.D.P., Hume E.B.H., Aliwarga Y., Kumar N., Cole N. Anovel cationic-peptide coating for the prevention of microbial colonization on contact lenses. JAppl Microbiol 2008, 105:1817-1825.
29. Shukla A., Fleming K.E., Chuang H.F., Chau T.M., Loose C.R., Stephanopoulos P.T., et al. Controlling the release of peptide antimicrobial agents from surfaces. Biomaterials 2010, 31:2348.
30. Willcox M.D.P., Hume E.B.H., Aliwarga Y., Kumar N., Cole N. Anovel cationic-peptide coating for the prevention of microbial colonization on contact lenses. JAppl Microbiol 2008, 105:1817.
31. Kazmierska K.A., Thompson R., Morris N., Long A., Ciach T. Invitro multicompartmental bladder model for assessing blockage of urinary catheters: effect of hydrogel coating on dynamics of Proteus mirabilis growth. Urology 2010, 76(515):e15-e20.
32. Burgos J.S., Ramirez C., Sastre I., Alfaro J.M., Valdivieso F. Herpes simplex virus type 1 infection via the bloodstream with apolipoprotein E dependence in the gonads is influenced by gender. JVirol 2005, 79:1605-1612.
33. Itzhaki R.F., Lin W.-R., Shang D., Wilcock G.K., Faragher B., Jamieson G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997, 349:241-244.
34. Itzhaki R.F., Dobson C.B., Shipley S.J., Wozniak M.A. The role of viruses and of APOE in dementia. Ann N Y Acad Sci 2004, 1019:15-18.
35. Kelly B., Harrison I., McKnight A., Dobson C. Anti-infective activity of apolipoprotein domain derived peptides invitro: identification of novel antimicrobial peptides related to apolipoprotein B with anti-HIV activity. BMC Immunol 2010, 11:13.
36. Dobson C.B., Sales S.D., Hoggard P., Wozniak M.A., Crutcher K.A. The receptor-binding region of human apolipoprotein E has direct anti-infective activity. JInfect Dis 2006, 193:442-450.
37. Rossignol T., Kelly B., Dobson C.B., d'Enfert C. Endocytosis-mediated vacuolar accumulation of the human apoE apolipoprotein-derived apoEdpL-W antimicrobial peptide contributes to its antifungal activity in Candida albicans. Antimicrob Agents Chemother 2011, 55:4670.
38. Gollwitzer H., Ibrahim K., Meyer H., Mittelmeier W., Busch R., Stemberger A. Antibacterial poly (d, l-lactic acid) coating of medical implants using a biodegradable drug delivery technology. JAntimicrob Chemother 2003, 51:585.
39. Balazs D.J., Triandafillu K., Wood P., Chevolot Y., van Delden C., Harms H., et al. Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments. Biomaterials 2004, 25:2139-2151.
40. Turner L.A., McCombs G.B., Hynes W.L., Tolle S.L. Anovel approach to controlling bacterial contamination on toothbrushes: chlorhexidine coating. Int J Dent Hyg 2009, 7:241-245.
41. Gilbert P., McBain A.J. Literature-based evaluation of the potential risks associated with impregnation of medical devices and implants with triclosan. Surg Infect (Larchmt) 2002, 3(Suppl. 1):S55-S63.
42. Müller G., Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. JAntimicrob Chemother 2008, 61:1281-1287.
43. Moore L.E., Ledder R.G., Gilbert P., McBain A.J. Invitro study of the effect of cationic biocides on bacterial population dynamics and susceptibility. Appl Environ Microbiol 2008, 74:4825.
44. Vogt B.D., Lin E.K., Wu W., White C.C. Effect of film thickness on the validity of the Sauerbrey equation for hydrated polyelectrolyte films. JPhys Chem B 2004, 108:12685.
45. Wilson A.P. Cytotoxicity and viability assays. Animal cell culture 2000, 175-219. Oxford University, Oxford. 3rd ed. J.R.W. Masters (Ed.).
46. Thermonuclease test 2010, National Standard Method BSOP TP 34. UK.
47. Keller C.A., Kasemo B. Surface specific kinetics of lipid vesicle adsorption measured with a quartz crystal microbalance. Biophys J 1998, 75:1397.
48. Mechler A., Praporski S., Atmuri K., Boland M., Separovic F., Martin L.L. Specific and selective peptide-membrane interactions revealed using quartz crystal microbalance. Biophys J 2007, 93:3907-3916.
49. Popplewell J., Freeman N., Carrington S., Ronan G., McDonnell C., Ford R.C. Quantification of the effects of melittin on liposome structure. Biochem Soc Trans 2005, 33:931.
50. Yu L., Guo L., Ding J.L., Ho B., Feng S., Popplewell J., et al. Interaction of an artificial antimicrobial peptide with lipid membranes. Biochim Biophys Acta 2009, 1788:333.
51. Lee T.H., Heng C., Swann M.J., Gehman J.D., Separovic F., Aguilar M.I. Real-time quantitative analysis of lipid disordering by aurein 1.2 during membrane adsorption, destabilisation and lysis. Biochim Biophys Acta 2010, 1798:1977.
52. Nielsen S.B., Otzen D.E. Impact of the antimicrobial peptide Novicidin on membrane structure and integrity. JColloid Interface Sci 2010, 345:248.
53. Sato H., Feix J.B. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides. Biochim Biophys Acta 2006, 1758:1245.
54. Vuong C., Voyich J.M., Fischer E.R., Braughton K.R., Whitney A.R., DeLeo F.R., et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004, 6:269-275.
55. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Micro 2005, 3:238-250.
56. Broxton P., Woodcock P.M., Heatley F., Gilbert P. Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. JAppl Microbiol 1984, 57:115-124.
57. Ikeda T., Ledwith A., Bamford C.H., Hann R.A. Interaction of a polymeric biguanide biocide with phospholipid membranes. Biochim Biophys Acta 1984, 769:57.
58. Majerle A., Kidrifç J., Jerala R. Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. JAntimicrob Chemother 2003, 51:1159-1165.
59. Chuanchuen R., Karkhoff-Schweizer R.R., Schweizer H.P. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am J Infect Control 2003, 31:124-127.
60. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
61. Brinster S., Lamberet G., Staels B., Trieu-Cuot P., Gruss A., Poyart C. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009, 458:83-86.
62. Javadpour M.M., Juban M.M., Lo W.-C.J., Bishop S.M., Alberty J.B., Cowell S.M., et al. De novo antimicrobial peptides with low mammalian cell toxicity. JMed Chem 1996, 39:3107-3113.